Cargando…
Obesity is associated with an impaired survival in lymphoma patients undergoing autologous stem cell transplantation
Autologous hematopoietic stem cell transplantation (auto-HSCT) provides a potentially curative treatment option for relapsed and refractory lymphomas. Obesity displays an emerging epidemic risk factor for global mortality and is associated with an increased mortality in cancer patients. To date, the...
Autores principales: | Scheich, Sebastian, Enßle, Julius C., Mücke, Victoria T., Acker, Fabian, Aspacher, Lukas, Wolf, Sebastian, Wilke, Anne C., Weber, Sarah, Brunnberg, Uta, Serve, Hubert, Steffen, Björn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839865/ https://www.ncbi.nlm.nih.gov/pubmed/31703102 http://dx.doi.org/10.1371/journal.pone.0225035 |
Ejemplares similares
-
KRAS Mutations in Squamous Cell Carcinomas of the Lung
por: Acker, Fabian, et al.
Publicado: (2021) -
Fluid overload is associated with increased 90-day mortality in AML patients undergoing induction chemotherapy
por: Ballo, Olivier, et al.
Publicado: (2021) -
Acute kidney injury adversely affects the clinical course of acute myeloid leukemia patients undergoing induction chemotherapy
por: Ballo, Olivier, et al.
Publicado: (2021) -
Treatment with midostaurin and other FLT3 targeting inhibitors is associated with an increased risk of cardiovascular adverse events in patients who underwent allogeneic hematopoietic stem cell transplantation with FLT3-mutated AML
por: Cremer, Anjali, et al.
Publicado: (2023) -
P1319: TREATMENT WITH MIDOSTAURIN AND OTHER FLT3 TARGETING INHIBITORS IS ASSOCIATED WITH AN INCREASED RISK OF CARDIOVASCULAR ADVERSE EVENTS IN PATIENTS WITH FLT3 MUTATED AML WHO UNDERWENT ALLOGENEIC HCT
por: Cremer, Anjali, et al.
Publicado: (2023)